Strs Ohio Makes New $1.72 Million Investment in Tempus AI, Inc. $TEM

Strs Ohio acquired a new stake in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 35,618 shares of the company’s stock, valued at approximately $1,718,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Cherry Tree Wealth Management LLC purchased a new stake in Tempus AI in the first quarter valued at about $31,000. University of Texas Texas AM Investment Management Co. purchased a new stake in shares of Tempus AI during the first quarter worth about $33,000. Continuum Advisory LLC acquired a new position in shares of Tempus AI during the first quarter valued at about $39,000. Bartlett & CO. Wealth Management LLC raised its position in shares of Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company’s stock valued at $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC acquired a new stake in Tempus AI in the 1st quarter worth approximately $39,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TEM has been the topic of a number of recent analyst reports. Bank of America upped their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a research note on Wednesday, June 25th. HC Wainwright upped their target price on Tempus AI from $90.00 to $98.00 and gave the company a “buy” rating in a research report on Friday, September 12th. Guggenheim raised their target price on Tempus AI from $65.00 to $75.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. BTIG Research boosted their price target on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, August 20th. Finally, Needham & Company LLC restated a “buy” rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and an average target price of $70.17.

Tempus AI Trading Up 2.2%

TEM stock opened at $87.04 on Wednesday. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58. The business’s 50-day moving average is $68.72 and its 200 day moving average is $60.01. The stock has a market cap of $15.12 billion, a price-to-earnings ratio of -73.14 and a beta of 5.08. Tempus AI, Inc. has a 12-month low of $31.36 and a 12-month high of $91.45.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.01. The firm had revenue of $314.64 million during the quarter, compared to analysts’ expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm’s revenue for the quarter was up 89.5% on a year-over-year basis. During the same period in the previous year, the business earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. On average, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity

In other news, EVP Andrew Polovin sold 5,398 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $402,960.70. Following the transaction, the executive vice president directly owned 132,056 shares in the company, valued at $9,857,980.40. The trade was a 3.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 27th. The shares were sold at an average price of $74.10, for a total value of $24,638,250.00. Following the completion of the sale, the chief executive officer owned 9,207,533 shares of the company’s stock, valued at $682,278,195.30. This trade represents a 3.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 601,787 shares of company stock valued at $42,492,268 in the last ninety days. 26.27% of the stock is currently owned by corporate insiders.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.